Gene · 6196
Papers2,567
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,567
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms. | Drug Des Devel Ther | 2023 | 37753228 | PubTator, text mining | PubMed |
| The C-terminal transactivation domain of MITF interacts promiscuously with co-activator CBP/p300. | Sci Rep | 2023 | 37752231 | PubTator, text mining | PubMed |
| The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways. | Cell Commun Signal | 2023 | 37735675 | PubTator, text mining | PubMed |
| Nucleophilic C4-selective (hetero) arylation of pyridines for facile synthesis of heterobiaryls. | Front Chem | 2023 | 37720719 | PubTator, text mining | PubMed |
| Signaling pathways in macrophages: molecular mechanisms and therapeutic targets. | MedComm (2020) | 2023 | 37706196 | PubTator, text mining | PubMed |
| Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ. | Nat Commun | 2023 | 37704624 | PubTator, text mining | PubMed |
| Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets. | J Pathol Clin Res | 2023 | 37697694 | PubTator, text mining | PubMed |
| Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment. | Neurobiol Dis | 2023 | 37689213 | PubTator, text mining | PubMed |
| Spice-Derived Phenolic Compounds: Potential for Skin Cancer Prevention and Therapy. | Molecules | 2023 | 37687080 | PubTator, text mining | PubMed |
| Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. | PLoS Pathog | 2023 | 37669313 | PubTator, text mining | PubMed |
| Kartogenin delivery systems for biomedical therapeutics and regenerative medicine. | Drug Deliv | 2023 | 37665332 | PubTator, text mining | PubMed |
| Small-Molecule Inhibition of KRAS through Conformational Selection. | ACS Omega | 2023 | 37663463 | PubTator, text mining | PubMed |
| RSK4 confers paclitaxel resistance to ovarian cancer cells, which is resensitized by its inhibitor BI-D1870. | Biochem Biophys Res Commun | 2023 | 37660640 | PubTator, text mining | PubMed |
| Research progress in the mechanism and treatment of osteosarcoma. | Chin Med J (Engl) | 2023 | 37649421 | PubTator, text mining | PubMed |
| Small extrachromosomal circular DNAs as biomarkers for multi-cancer diagnosis and monitoring. | Clin Transl Med | 2023 | 37649244 | PubTator, text mining | PubMed |
| A stepwise and digital pattern of RSK phosphorylation determines the outcome of thymic selection. | iScience | 2023 | 37646020 | PubTator, text mining | PubMed |
| Fisetin overcomes non-targetability of mutated KRAS induced YB-1 signaling in colorectal cancer cells and improves radiosensitivity by blocking repair of radiation-induced DNA double-strand breaks. | Radiother Oncol | 2023 | 37634766 | PubTator, text mining | PubMed |
| Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets. | Leukemia | 2023 | 37634012 | PubTator, text mining | PubMed |
| Vegetable as a Source of Bioactive Compounds with Photoprotective Properties: Implication in the Aging Process. | Nutrients | 2023 | 37630784 | PubTator, text mining | PubMed |
| Three-Dimensional Pore Structure Characterization of Bituminous Coal and Its Relationship with Adsorption Capacity. | Materials (Basel) | 2023 | 37629854 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6196/papers?page=9